Precigen (PGEN) Non-Current Deffered Revenue (2012 - 2025)

Precigen's (PGEN) quarterly Non-Current Deffered Revenue came in at $95000.0 in Q3 2025, down 95.32% year-on-year from $2.0 million in Q3 2024, and down 94.77% on a QoQ basis from $1.8 million in Q2 2025.

Precigen (PGEN) Non-Current Deffered Revenue (2012 - 2025) Analysis & Trends

Precigen (PGEN) has 14 years of Non-Current Deffered Revenue data on file, last reported at $95000.0 in Q3 2025.

  • On a quarterly basis, Non-Current Deffered Revenue fell 95.32% year-over-year to $95000.0 in Q3 2025; TTM through Sep 2025 was $95000.0, a 95.32% decrease from a year earlier, with the FY2024 full-year figure at $1.9 million, up 6.38% from the prior year.
  • Non-Current Deffered Revenue for Q3 2025 stood at $95000.0, down from $1.8 million in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for PGEN reached as high as $23.0 million in Q1 2021 and fell as low as $95000.0 in Q3 2025.
  • Historically, Non-Current Deffered Revenue has averaged $8.4 million across 5 years, with a median of $1.8 million in 2025.
  • Across the five-year window, Non-Current Deffered Revenue increased 11.77% in 2024 and plunged 95.32% in 2025, its largest moves.
  • Year by year, Non-Current Deffered Revenue stood at $23.0 million in 2021, then plunged by 92.1% to $1.8 million in 2022, then changed by 0.0% to $1.8 million in 2023, then gained by 6.38% to $1.9 million in 2024, then slumped by 95.09% to $95000.0 in 2025.
  • Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $95000.0 in Q3 2025, $1.8 million in Q2 2025, and $1.8 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 225.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Precigen 1.96 Bn 1.96 Bn 20.69 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 95,000.00
Jun 30, 2025 1.82 Mn
Mar 31, 2025 1.84 Mn
Dec 31, 2024 1.93 Mn
Sep 30, 2024 2.03 Mn
Jun 30, 2024 1.82 Mn
Mar 31, 2024 1.89 Mn
Dec 31, 2023 1.82 Mn
Sep 30, 2023 1.82 Mn
Jun 30, 2023 1.82 Mn
Mar 31, 2023 1.82 Mn
Dec 31, 2022 1.82 Mn
Sep 30, 2022 1.82 Mn
Jun 30, 2022 23.02 Mn
Mar 31, 2022 23.02 Mn
Dec 31, 2021 23.02 Mn
Sep 30, 2021 23.02 Mn
Jun 30, 2021 23.02 Mn
Mar 31, 2021 23.02 Mn
Dec 31, 2020 23.02 Mn